Chemoinformaics analysis of ALLYL ISOBUTYL SULFIDE
| Molecular Weight | 130.256 | nRot | 4 |
| Heavy Atom Molecular Weight | 116.144 | nRig | 1 |
| Exact Molecular Weight | 130.082 | nRing | 0 |
| Solubility: LogS | -2.794 | nHRing | 0 |
| Solubility: LogP | 3.091 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 23.9251 |
| nHD | 0 | BPOL | 16.5049 |
| QED | 0.416 |
| Synth | 2.824 |
| Natural Product Likeliness | -0.197 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.476 |
| MDCK | 0.0000328 |
| BBB | 0.97 |
| PPB | 0.802193 |
| VDSS | 1.32 |
| FU | 0.0882367 |
| CYP1A2-inh | 0.897 |
| CYP1A2-sub | 0.68 |
| CYP2c19-inh | 0.471 |
| CYP2c19-sub | 0.862 |
| CYP2c9-inh | 0.154 |
| CYP2c9-sub | 0.851 |
| CYP2d6-inh | 0.086 |
| CYP2d6-sub | 0.743 |
| CYP3a4-inh | 0.274 |
| CYP3a4-sub | 0.299 |
| CL | 12.028 |
| T12 | 0.713 |
| hERG | 0.008 |
| Ames | 0.03 |
| ROA | 0.028 |
| SkinSen | 0.919 |
| Carcinogencity | 0.662 |
| EI | 0.995 |
| Respiratory | 0.179 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.95604 |